openPR Logo
Press release

Asia-Pacific Cancer Monoclonal Antibodies Market Size, Share, Future Prospects and Forecast 2020-2026

11-18-2020 12:19 PM CET | Health & Medicine

Press release from: Orion Market Research

Asia-Pacific Cancer Monoclonal Antibodies Market Size, Share,

Asia-Pacific cancer monoclonal antibodies market is estimated to grow at a CAGR of 11.2% during the forecast period. Increasing awareness regarding cancer is one of the pivotal factors accelerating market growth. Biopharmaceutical firms have reported the launch of public awareness campaigns for cancer. For instance, in May 2016 Roche launched a public awareness campaign known as ‘Run for Her’. This campaign aims to deliver successfully crucial messages regarding the need for breast cancer screening in women frequently. Early diagnosis and consistent treatment can lead to improving disease outcomes and quality of life of breast cancer patients.

A full Report of Asia-Pacific Cancer Monoclonal Antibodies Market Available at https://www.omrglobal.com/industry-reports/asia-pacific-cancer-monoclonal-antibodies-market

The company organized this campaign in collaboration with the China Cancer Rehabilitation Society, to increase public awareness regarding breast cancer. This initiative can support improving awareness, testing, and therapeutics of breast cancer in China, which in turn, will accelerate the demand for monoclonal antibody treatment that serves as one of the established therapeutic strategies for both solid tumors and hematologic malignancies. It is a type of immunotherapy that stimulates the immune system of cancer patients and works to recognize and attack cancer cells.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-cancer-monoclonal-antibodies-market

Scope of the Asia-Pacific Cancer Monoclonal Antibodies Market

Market Coverage

• Market number available for 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Type and Application
• Regions Covered- China, India, Japan, and Rest of Asia-Pacific
• Competitive Landscape- Biocon Ltd., Amgen Inc., F. Hoffman La-Roche AG, Pfizer Inc., and Mylan N.V.

Recent Strategic Initiatives in the Asia-Pacific Cancer Monoclonal Antibodies Market

• In July 2020, Ahmedabad-based Cadila Pharmaceuticals Ltd. declared the introduction of biosimilar Rituximab in India. It is indicated for the treatment of rheumatoid arthritis and blood cancer launched within the brand name Ritucad. It is used to treat Non-Hodgkin’s lymphoma (a type of blood-related cancer). According to the company, over 28,000 new cases of Lymphoma are reported each year in India. This launch will increase the accessibility of cancer treatment in the country.
• In October 2019, Amgen declared collaboration with BeiGene that will further widen Amgen's plans to enhance its oncology presence in China. Under the agreement, BeiGene will commercialize BLINCYTO (blinatumomab), XGEVA (denosumab), and KYPROLIS (carfilzomib) in China. Additionally, this acquisition will also support Amgen for the commercialization of its non-oncology product portfolio in China.

Key questions addressed by the report

• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• How COVID-19 impacted the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Asia-Pacific Cancer Monoclonal Antibodies Market-Segmentation

By Type

• Naked
• Conjugated
• Others (Bispecific)

By Application

• Breast Cancer
• Liver Cancer
• Blood Cancer
• Brain Cancer
• Colorectal Cancer
• Others

Asia-Pacific Cancer Monoclonal Antibodies Market– Segment by Country

• China
• Japan
• India
• Rest of Asia-Pacific

Company Profiles

• Amgen Inc.
• Anhui Anke Biotechnology (Group) Co., Ltd.
• Biocon Ltd.
• Chugai Pharmaceutical Co., Ltd.
• Daiichi Sankyo Company, Ltd.
• Dr. Reddy's Laboratories, Inc.
• Genor BioPharma Co., Ltd.
• Lupin Ltd.
• Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
• Takeda Pharmaceutical Co., Ltd.
• Zhejiang Hisun Pharmaceutical Co., Ltd.

For More Customized Data, Request for Report Customization https://www.omrglobal.com/report-customization/asia-pacific-cancer-monoclonal-antibodies-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific Cancer Monoclonal Antibodies Market Size, Share, Future Prospects and Forecast 2020-2026 here

News-ID: 2189708 • Views:

More Releases from Orion Market Research

Used Cooking Oil Market Development, Industry Trends, Demand and Growth Analysis and Forecasts 2033
Used Cooking Oil Market Development, Industry Trends, Demand and Growth Analysis …
The global Used Cooking Oil (UCO) Market was valued at approximately USD 6.1 billion in 2023 and is projected to reach around USD 11.8 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of about 7.5% from 2024 to 2032. Used Cooking Oil Market Overview The Used Cooking Oil Market is gaining traction globally, driven by rising demand for sustainable biofuels, particularly biodiesel. Governments and environmental bodies are
Loader Buckets Market to see Huge Growth by 2028
Loader Buckets Market to see Huge Growth by 2028
Market experts do detailed market study about entire market from several angles to depict the most updated and key market data to form this detailed Loader Buckets Market research report and help startups to reinforce their presence. This report further aims at covering vital data and figures on major areas such Asia Pacific, North America, Middle East, Europe, Latin America and Africa.  Business participants can also obtain larger gains as
Probiotics Supplement Market Trends, Business Overview, Industry Growth and Fore …
The global probiotics supplement market is anticipated to grow at a significant CAGR of 7.2% during the forecast period (2022-2028). The rising consumer awareness for healthcare and fitness with rising disposable income, are likely to drive the market growth. Probiotics enable to maintenance of a healthy balance of gut flora and have been linked to a variety of health advantages, including weight loss, digestive health, and immunological function. The market
Brick Pavers Market Top Leading Players with Strategies and Forecast 2028
Brick Pavers Market Size, Share & Trends Analysis is a professional and in-depth study on the current state of the global Brick Pavers market with a focus on the  market. The report provides key statistics on market of Brick Pavers. It is a valuable source of guidance and direction for companies and individuals interested in Brick Pavers industry. Key Players Belgard Acme Brick Company The Belden Brick Company Wienerberger Pine Hall Brick Redland Brick   By Type General Brick Pavers Wall

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For